cdmo.directory
← Compare landing

JYMed Peptide vs Neuland Laboratories

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/jymedtech/neulandlabs

CategoryJYMed PeptideNeuland Laboratories
Listed sitecdmocdmo
SummaryPeptide CDMO offering custom synthesis from milligrams to metric tons, with 13 cGMP lines and FDA-, NMPA- and EDQM-approved sites. Provides peptide API manufacturing plus syringe, cartridge and lyophilized finished-dose filling at its Shenzhen site.Global API CDMO supporting biotechnology and pharmaceutical companies in design, development, and manufacturing of complex active pharmaceutical ingredients from early-stage drug development through commercial scale.
Services
  • Peptide Manufacturing
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Lyophilization (Freeze Drying)
  • Cartridge Filling
  • Prefilled Syringe (PFS) Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Secondary Packaging & Labeling
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Peptide Manufacturing
Modalities
  • Peptide
  • Small Molecule
  • Peptide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Shenzhen headquarters, Shenzhen, Guangdong, China
  • Shenzhen R&D Center, Shenzhen, Guangdong, China
  • Shenzhen FDF manufacturing site, Shenzhen, Guangdong, China
  • Hubei API manufacturing site, Hubei, China
  • R&D Centre, India
  • Unit I - Bonthapally, Bonthapally, India
  • Unit II - Pashamylaram, Pashamylaram, India
  • Unit III - Gaddapotharam, Gaddapotharam, India
  • Upcoming Peptide Facility, India
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.